In 2025, the US offers diverse alternatives to Xiidra for dry eye disease management, including Signal12's Pro-ocularâ„¢, harnessing advanced delivery systems in Greenwich, and Olympic Ophthalmics' iTEAR100 neuromodulation device from Issaquah. Firms like Inoculus Ventures in Raleigh advance laboratory diagnostics, while Summit Eye Center in Lee's Summit delivers tailored surgeries. Across California, entities like East Bay Eye Center and Beach Eye Medical Group excel in vision health. These companies uniquely address dry eye with proprietary solutions, cutting-edge diagnostics, and patient-focused care.
Signal12 is a clinical-stage biopharmaceutical firm specializing in innovative drug therapies for Dry Eye Disease, notably through its proprietary topical treatment, Pro-ocularâ„¢, which employs a unique transappendageal delivery system and targets the ophthalmic branch of the trigeminal nerve.
Olympic Ophthalmics specializes in medical equipment manufacturing, focusing on innovative drug-free home-health solutions for ocular diseases. Their flagship product, the iTEAR100, utilizes neuromodulation technology to enhance natural tear production, addressing significant unmet needs in eye care.
ReVision Therapeutics focuses on developing innovative ophthalmic medicines by repurposing approved drugs and rescuing shelved therapies to address unmet needs in eye disorders. Their unique approach allows for faster and more cost-effective development of impactful treatments, including options for Stargardt disease and dry eye disease.
Inoculus Ventures specializes in developing innovative treatments for dry eye disease within the medical and diagnostic laboratories industry. Their focus on novel therapeutic solutions positions them as a key player in addressing this prevalent condition.
Cure Stat Rx specializes in pharmaceutical manufacturing, focusing on home infusion and specialty pharmacy services that provide high-quality compounded and specialty medications. With a commitment to pioneering treatments for rare and chronic diseases, it offers personalized service and competitive pricing, along with expertise in various therapeutic areas including oncology, immunotherapy, and pediatric compounding.
Summit Eye Center is a comprehensive ophthalmology practice specializing in cataract surgery, glaucoma treatment, and dry eye disease management, employing innovative, minimally invasive techniques and a tailored approach to patient care. The focus on advanced lens implant options and a wide range of treatments in a welcoming environment sets it apart in the medical practices industry.
Oculos Clinical is a full-service ophthalmic research organization specializing in pharmaceutical manufacturing, offering integrated solutions for pre-clinical testing, clinical research, and product development across various ophthalmological conditions. With a focus on delivering a complete product pathway from research to release, it leverages extensive expertise in clinical research, medical devices, and analytical chemistry.
AxeroVision specializes in biotechnology research focused on developing innovative therapies for ophthalmic inflammatory diseases, particularly Dry Eye Disease and Meibomian Gland Dysfunction. Their lead candidates, AXR-159 and AXR-270, have demonstrated clinical proof-of-concept, highlighting their commitment to breakthrough treatments in the field of ophthalmology.
BioTheraVision specializes in advanced biotherapeutics, focusing on innovative solutions for disease treatment and prevention through cutting-edge research and development in the biotechnology industry. Their unique approach combines state-of-the-art technology with a commitment to improving patient outcomes.
Harrow is a leader in the ophthalmic pharmaceutical manufacturing industry, focusing on innovation and the provision of affordable, accessible medications. Its commitment to understanding the needs of healthcare providers and patients positions it as one of the fastest-growing entities in the ophthalmic healthcare market.
A biopharmaceutical firm specializing in the development and commercialization of innovative ophthalmic therapies, utilizing proprietary bioresorbable hydrogel technology to enhance drug delivery solutions. Their product pipeline includes FDA-approved treatments for ocular inflammation, pain, and elevated intraocular pressure, positioning them as a leader in the ophthalmic sector.
Bruder Healthcare specializes in the manufacturing of innovative medical equipment focused on ocular health and wellness, offering a range of therapeutic products for dry eye management and natural pain relief. Their patented technologies emphasize safety, efficacy, and convenience, making them a leader in the therapeutic eyecare industry.
Visus Therapeutics is a clinical-stage biotechnology firm dedicated to developing innovative ophthalmic therapies aimed at enhancing vision, particularly targeting presbyopia through novel once-daily eye drops. The focus on advanced drug delivery technology and a diverse pipeline addressing various eye conditions positions it uniquely in the ophthalmology sector.
An innovation-driven clinical-stage biotechnology firm focused on developing ophthalmic drugs for chronic eye diseases, featuring a diverse pipeline of seven drug candidates. Notably, its lead candidate, CBT-001, aims to address pterygium, an underdiagnosed condition with no existing approved treatments, through targeted mechanisms and specialized formulations for ocular delivery.
Specializing in medical equipment manufacturing, OcuSci Inc. develops innovative products for the treatment of Dry Eye Disease, including the clinically proven MGrx Dry Eye Treatment System for in-clinic use and a best-in-class Dry Eye Compress that offers therapeutic moist-heat therapy. Their solutions provide rapid symptom relief and significant improvement within a month, addressing various related conditions effectively.
Eye Eco, Inc. is a medical device firm focused on developing innovative products and therapies that provide natural, long-lasting relief for dry, irritated eyes while promoting overall eye health. The organization emphasizes comfort and effectiveness in its offerings and actively contributes to charitable efforts aimed at curing chronic dry eye conditions.
Oculus Research specializes in ophthalmic clinical research, focusing on a wide range of eye conditions and innovative treatment devices. With a patient-centered approach and extensive clinical research experience, it aims to advance pharmaceutical development in the field of optometry.
Belite Bio is a clinical-stage biotechnology firm focused on developing innovative treatments for untreatable eye diseases and metabolic disorders, with a lead oral therapy, Tinlarebant, currently in phase 3 trials and recognized with multiple designations for its potential in addressing Dry AMD and Stargardt disease.
ForSight VISION5 specializes in pharmaceutical manufacturing, focusing on innovative, non-invasive products that replace traditional eye drops for sustained therapy in treating major anterior segment eye diseases, such as glaucoma and dry eye. Its lead product, the Helios(TM) insert, offers a novel delivery system that ensures continuous medication administration for patients.
MIEBO® is an ophthalmic solution in the pharmaceutical manufacturing industry, specializing in innovative treatments for eye care. Its unique formulation is designed to enhance ocular surface health, catering specifically to healthcare professionals in the U.S. market.
Updated on
Save time, improve accuracy, and get ahead of the competition with Cenco.ai.
Get startedTop 26 Customer Satisfaction Survey Companies
Discover the Top 26 Customer Satisfaction Survey Companies in the US, offering unique solutions across industries to enhance client experiences.
Top 24 Broadcasting Companies in the US
Explore the top 24 broadcasting companies in the US, highlighting unique strategies and regional focuses in the competitive broadcast media landscape.
Top Cruise Companies in the US
Discover the top cruise companies in the US, offering unique travel arrangements and exceptional services for discerning travelers.